Venture Capital
Excited to announce our investment alongside Bonfire Ventures, Insight Partners and the Allen Institute for AI in the $4M seed for...
This is a continuation of the article: Medicare / Medicaid / Advantage — Where Are The Opportunities For Startups? — Part...
AmplifyMD is a platform for all specialty needs: it connects. Excited to be investors alongside F Prime (Fidelity), Greylock and Forerunner...
Excited to announce our investment in Arpeggio Bio, which engineers drugs to change the transcriptome, with the goal of making safer...
Medicare, Medicaid, Medicare Advantage. The words often get thrown around and are mixed with generalized association of government social programs for...
“July 21, 2022 at 8:30 AM EDT – Amazon and One Medical Sign an Agreement for Amazon to Acquire One Medical...
The COVID pandemic has catalyzed an unimaginably rapid adoption of virtual care. Virtual disease management service offerings, and the demand for...
A startup worth evaluation reminds me of a coin toss. With no operational value, real income, or сlear-eyed market feedback, tangible...
Direct-to-consumer healthcare. We see it more and more, and it is an increasing trend that’s been written about extensively (see: health-tech...
As the economy takes a downturn in the second quarter of 2022, and gloomy projections of the market have translated into...
You hear these terms all the time. Countless articles (here, here, here) enumerate the various metrics that can quantify the growth...
Excited to announce our investment alongside General Catalyst, Resolute, Canaan and The Fund in the $7M seed of Hank, which helps...
This blog has talked at length in the past about how to raise a round, especially a seed, and building an...
A previous article Secondaries: Founders and Investors defined a secondary as when you sell your existing shares to another investor. Secondaries...
4Ps, PPO, HMO, MCO, ACO, VFVB, CMS, PMPM, PBM – the list of acronyms is long, see Appendix. But cut through...
The earlier a startup is, the more buffered it’s from the ups and downs of public markets. But buffered doesn’t mean...
Excited to announce our investment in Resilient Lifescience, which is taking on the opioid epidemic by developing a wearable system to...
Most startups will face the prospect of a lower valuation than they wanted at some point. Which is why raising too...
Tau Ventures focuses on AI investments in healthcare and enterprise, but we are also fascinated by automation and very occasionally invest...
Excited to announce our investment alongside Softbank (Upload Ventures), Aggir and Norte in the now oversubscribed $2M seed of Salú, which...
The short answer is most definitely yes. While every situation is unique, the three cases below provide a framework around the...
The two years between Jan 1, 2020 to Jan 1, 2022 have been especially bullish for startup fundraising – (i) more...
This is an article meant primarily for entrepreneurs and LPs (limited partners i.e., those investing in a VC fund), albeit we...
Pitch decks are a topic of permanent debate, no matter how much has been written about them. As such, this article...
Load More Posts
